Zarur Juan Andrey 4

Accession 0001062993-22-002726

CIK 0001822691other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 7:26 PM ET

Size

18.5 KB

Accession

0001062993-22-002726

Form 4

Period: 2022-02-02

DirectorPresident & CEO

Transactions

Award
Common Stock
2022-02-02+896,058→ 896,058 total
Award
Stock Option (Right to Buy)
2022-02-02+70,319→ 70,319 total
Exercise: $0.35Exp: 2023-07-29→ Common Stock (70,319 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+926,330→ 926,330 total
Exercise: $0.33Exp: 2028-09-13→ Common Stock (926,330 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+1,982,609→ 1,982,609 total
Exercise: $0.50Exp: 2029-12-29→ Common Stock (1,982,609 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+668,830→ 668,830 total
Exercise: $0.50Exp: 2029-12-29→ Common Stock (668,830 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+1,906,944→ 1,906,944 total
Exercise: $0.98Exp: 2030-12-01→ Common Stock (1,906,944 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+292,649→ 292,649 total
Exercise: $0.98Exp: 2030-12-01→ Common Stock (292,649 underlying)

Footnotes (8)

[F1]Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
[F2]100% of the shares subject to this option are fully vested and exercisable.
[F3]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
[F4]20% of the shares underlying the option vested or shall vest on September 12, 2018 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
[F5]20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021.
[F6]20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021.
[F7]25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.
[F8]25% of the shares underlying the option vested or shall vest after one year of service and the remainder of the shares vested or shall vest in 36 equal monthly installments.

Documents

1 file

GreenLight Biosciences Holdings, PBC

CIK 0001822691

Entity typeother